Results 11 to 20 of about 399,116 (301)
Prognostic biomarkers of cutaneous melanoma [PDF]
Photodermatology, Photoimmunology & Photomedicine, 2022 AbstractBackground/purposeMelanomas account for only approximately 4% of diagnosed skin cancers in the United States but are responsible for the majority of deaths caused by skin cancer. Both genetic factors and ultraviolet (UV) radiation exposure play a role in the development of melanoma.
Liang, Ding +6 more
openaire +2 more sources
Prognostic biomarkers in osteoarthritis [PDF]
Current Opinion in Rheumatology, 2013 Identification of patients at risk for incident disease or disease progression in osteoarthritis remains challenging, as radiography is an insensitive reflection of molecular changes that presage cartilage and bone abnormalities. Thus there is a widely appreciated need for biochemical and imaging biomarkers.
Mukundan, Attur +3 more
openaire +2 more sources
Prognostic Biomarkers for Melanoma Immunotherapy [PDF]
Current Oncology Reports, 2020 Recent developments in immunotherapy have transformed the landscape of melanoma therapy. Here, we review markers for response to immunotherapy.Current immunotherapies disable immune checkpoints on T cells and other immune cells and allow immune rejection of tumor.
Twitty, Christopher G +2 more
openaire +4 more sources
Editorial: Prognostic biomarkers for oral cancer
Frontiers in Oral Health, 2022 Non peer ...
Sabrina Wurzba +4 more
openaire +4 more sources
An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automati c Prognosis of MCI Patients [PDF]
, 2011 Alzheimer's disease (AD) and mild cognitive impairment (MCI), continue to be widely studied. While there is no consensus on whether MCIs actually "convert" to AD, the more important question is not whether MCIs convert, but what is the best such ...
Aksu, Yaman +4 more
core +11 more sources
The Journal of Pathology: Clinical Research, 2021 Immune cell infiltration has been identified as a prognostic biomarker in several cancers. However, no immune based biomarker has yet been validated for use in pancreatic ductal adenocarcinoma (PDAC). We undertook a systematic review and meta‐analysis of
Andrew J McGuigan +6 more
doaj +1 more source
Molecular Markers in Guiding Lung Cancer Diagnosis and Treatment
Journal of Men's Health, 2022 Background: Lung cancer has the highest mortality rates and one of the lowest 5-year survival rates amongst cancer types in the world. Although there are constant advancements in treatment, the overall prognosis for lung cancer continues to be poor.
Vivian Li, Wickii T. Vigneswaran
doaj +1 more source
Prognostic value of miR-21 in various cancers: an updating meta-analysis. [PDF]
PLoS ONE, 2014 Recently, more and more studies investigated the value of microRNA (miRNA) as a diagnostic or prognostic biomarker in various cancers. MiR-21 was found dysregulated in almost all types of cancers.
Xin Zhou +6 more
doaj +1 more source
Prognostic Value of Colorectal Cancer Biomarkers [PDF]
Cancers, 2011 Despite the large amount of data in cancer biology and many studies into the likely survival of colorectal cancer (CRC) patients, knowledge regarding the issue of CRC prognostic biomarkers remains poor. The Tumor-Node-Metastasis (TNM) staging system continues to be the most powerful and reliable predictor of the clinical outcome of CRC patients.
P. Bianchi +3 more
openaire +3 more sources
BMJ Open, 2021 Introduction Sepsis is a dysregulated host response to infection characterised by activation of proinflammatory and procoagulant mechanisms. Protein C (PC)’s activity as an anticoagulant and antiinflammatory molecule makes it an appealing target for ...
Alison Fox-Robichaud +3 more
doaj +1 more source